Procaps Group, S.A Retained Earnings (Accumulated Deficit) 2020-2023 | PROCF
Procaps Group, S.A retained earnings (accumulated deficit) from 2020 to 2023. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.
Procaps Group, S.A Annual Retained Earnings (Accumulated Deficit) (Millions of US $) |
2022 |
$-392 |
2021 |
$-431 |
2020 |
$-327 |
2020 |
$-13 |
2019 |
$ |
2019 |
$-0 |
2018 |
$-0 |
Procaps Group, S.A Quarterly Retained Earnings (Accumulated Deficit) (Millions of US $) |
2023-09-30 |
$-354 |
2023-06-30 |
$-362 |
2023-03-31 |
$-385 |
2022-12-31 |
$-392 |
2022-09-30 |
$-402 |
2022-06-30 |
$-425 |
2022-03-31 |
$-418 |
2021-12-31 |
$-431 |
2021-09-30 |
|
2021-06-30 |
$-29 |
2021-03-31 |
$-23 |
2020-12-31 |
$-327 |
2020-09-30 |
$-13 |
2020-06-30 |
$1 |
2020-03-31 |
$1 |
2019-12-31 |
$0 |
2019-09-30 |
$-0 |
2019-06-30 |
|
2019-03-31 |
|
Sector |
Industry |
Market Cap |
Revenue |
Medical |
MED-DRUGS |
$0.125B |
$0.410B |
Procaps Group is a developer of pharmaceutical and nutraceutical solutions, medicines and hospital supplies. It develops, manufactures and markets over-the-counter and prescription drugs, nutritional supplements and high-potency clinical solutions. Procaps Group, formerly known as Union Acquisition Corp. II, is based in BARRANQUILLA, Colombia.
|